PENUMBRA INC

 PENのチャート


 PENの企業情報

symbol PEN
会社名 Penumbra Inc (PENUMBRA INC)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 ペナムブラ(Penumbra Inc.)は介入療法に従事するヘルスケア会社である。同社は医療機器の設計・開発・製造・販売を行う。同社は神経および末梢血管の2つの市場における医療状況および臨床ニーズに対応する製品ポートフォリオを有する。その製品が扱う条件には、虚血性脳卒中、出血性脳卒中、および血栓摘出および塞栓形成処置によって治療することができる多様な末梢血管状態が含まれる。同社は介入ニューロラジオロジスト、神経外科医、介入神経学者、介入放射線医および血管外科医を含む、専門医による使用のための製品の開発・製造・販売を行う。その神経製品には、神経血管アクセス、神経血栓摘出(虚血性脳卒中)、神経血管塞栓(脳動脈瘤)および神経外科ツール(出血性脳卒中)が含まれる。その末梢血管製品には、末梢血管塞栓術および末梢血栓摘除術が含まれる。  ペナンブラは米国の医療器具メ―カ―。主に、神経系と周辺血管向け医療器具の開発、製造、商業化に従事する。同社の主要製品は、虚血性脳卒中や出血性脳卒中など周辺血管における疾患に対し、梗塞を防ぐために速やかに行う血栓摘出術や血管塞栓術の際に使用される。同社独自ル―トや卸売業者を通じ、米国内外の病院に販売される。本社はカリフォルニア州。  
本社所在地 One Penumbra Place Alameda CA 94502 USA
代表者氏名 Adam Elsesser
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 510-995-2486
設立年月日 2004年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 2200人
url www.penumbrainc.com
nasdaq_url
adr_tso
EBITDA (百万ドル) 36.15100
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 4884.71100
売上高 (百万ドル) 444.93800
企業価値(EV) (百万ドル) 4683.82200
当期純利益 (百万ドル) 6.58800
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Penumbra Inc revenues increased 33% to $444.9M. Net income before extraordinary items decreased 70% to $6.7M. Revenues reflect United States segment increase of 33% to $290.7M Other International segment increase of 39% to $112.4M. Net income was offset by Sales General and Administrative -Other increase of 25% to $209.2M (expense) Research and Development - Other increase of 14% to $34.6M (expense).

 PENのテクニカル分析


 PENのニュース

   Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism  2020/11/20 13:00:00 Business Wire
ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #aspiration--Penumbra's Indigo Aspiration System Lightning 12 received FDA clearance for the treatment of pulmonary embolism.
   Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism  2020/11/10 11:00:00 PR Newswire
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures…
   Neurovascular Devices Market Survey on Developing Application 2025 | Johnson & Johnson (Depuy), Medtronic, Stryker, Terumo, and Penumbra  2020/11/06 11:26:03 OpenPR
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In
   Pinterest, Inphi: 5 Top Stock Gainers for Thursday  2020/10/29 17:16:43 The Street
Inphi, Nic, Pinterest, Penumbra and Meta Financial are five top stock gainers for Thursday.
   Neurointerventional Devices Market Is Anticipated To Reach Us$ 4,524.34 Mn In 2027 With Medtronic, Stryker, iVascular S.L.U., Terumo Corporation, Boston Scientific Corporation, Merit Medical Systems, Penumbra, Inc., Rapid Medical, MicroPort Scientific Cor  2020/10/28 13:16:40 OpenPR
This research report will give you deep insights about the Neurointerventional Devices Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually
   Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism  2020/11/20 13:00:00 Business Wire
ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #aspiration--Penumbra's Indigo Aspiration System Lightning 12 received FDA clearance for the treatment of pulmonary embolism.
   Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism  2020/11/10 11:00:00 PR Newswire
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures…
   Neurovascular Devices Market Survey on Developing Application 2025 | Johnson & Johnson (Depuy), Medtronic, Stryker, Terumo, and Penumbra  2020/11/06 11:26:03 OpenPR
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In
   Pinterest, Inphi: 5 Top Stock Gainers for Thursday  2020/10/29 17:16:43 The Street
Inphi, Nic, Pinterest, Penumbra and Meta Financial are five top stock gainers for Thursday.
   Neurointerventional Devices Market Is Anticipated To Reach Us$ 4,524.34 Mn In 2027 With Medtronic, Stryker, iVascular S.L.U., Terumo Corporation, Boston Scientific Corporation, Merit Medical Systems, Penumbra, Inc., Rapid Medical, MicroPort Scientific Cor  2020/10/28 13:16:40 OpenPR
This research report will give you deep insights about the Neurointerventional Devices Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually
   Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism  2020/11/20 13:00:00 Business Wire
ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #aspiration--Penumbra's Indigo Aspiration System Lightning 12 received FDA clearance for the treatment of pulmonary embolism.
   Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism  2020/11/10 11:00:00 PR Newswire
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures…
   Neurovascular Devices Market Survey on Developing Application 2025 | Johnson & Johnson (Depuy), Medtronic, Stryker, Terumo, and Penumbra  2020/11/06 11:26:03 OpenPR
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In
   Pinterest, Inphi: 5 Top Stock Gainers for Thursday  2020/10/29 17:16:43 The Street
Inphi, Nic, Pinterest, Penumbra and Meta Financial are five top stock gainers for Thursday.
   Neurointerventional Devices Market Is Anticipated To Reach Us$ 4,524.34 Mn In 2027 With Medtronic, Stryker, iVascular S.L.U., Terumo Corporation, Boston Scientific Corporation, Merit Medical Systems, Penumbra, Inc., Rapid Medical, MicroPort Scientific Cor  2020/10/28 13:16:40 OpenPR
This research report will give you deep insights about the Neurointerventional Devices Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 PENUMBRA INC PEN )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)